Updated:
Foresite Capital
Foresite Capital is a multi-stage healthcare and life sciences investment firm with ~ $3.5B in assets under management (as of 06/30/24). The firm aims to...
Foresite Capital
Foresite Capital is a multi-stage healthcare and life sciences investment firm with ~ $3.5B in assets under management (as of 06/30/24). The firm aims to address areas of great unmet need by funding promising healthcare and life sciences businesses at all stages of their life cycles. Foresite Capital uses a data science-driven approach to invest in companies that leverage biology and big data to transform healthcare, including 10x Genomics, Relay Therapeutics, Element Biosciences, Inscripta, as well as companies developing next generation therapeutics. Founded in 2011, Foresite Capital is based in San Francisco.
General information
Firm type
Private Equity
Year founded
2011
AUM
$3.5B (Altss estimate)
Location
Region
North America
Country
United States
City
West Hollywood
Corporate office
—
Principals
Hadi Tabbaa
Managing Director and Head of Investor Relations and Business Development
Altss tracks 1 additional named team member for this firm — including direct investment leads, IR, and operating principals not listed on the public website.
Book a demoSector focus
Frequently asked questions
Who runs investment decisions at Foresite Capital?
Jim Tananbaum serves as Founder and CEO. Hadi Tabbaa leads investor relations and business development.
What asset classes does Foresite Capital deploy into?
The firm targets venture capital, growth equity and PIPE transactions in healthcare and life sciences.
Does Foresite Capital participate in fund commitments or only direct deals?
Records indicate both direct co-investments and SPVs alongside private equity commitments.
Which sectors does Foresite Capital focus on?
Confirmed sectors include Digital Health, Healthcare Services, Biotechnology and Data Analytics.
Where does Foresite Capital invest geographically?
The firm concentrates on North America.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: